Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreatic Carcinoma”

640 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 640 results

Early research (Phase 1)Looking for participantsNCT06673017
What this trial is testing

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma+1 more
PanTher Therapeutics 26
Testing effectiveness (Phase 2)Study completedNCT02810418
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

Who this might be right for
NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT07296341
What this trial is testing

HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer With
Shanghai Hengrui Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Large-scale testing (Phase 3)Study completedNCT03984214
What this trial is testing

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic
Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Large-scale testing (Phase 3)Study completedNCT00471146
What this trial is testing

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Who this might be right for
Carcinoma, Pancreatic Ductal
Pfizer 630
Testing effectiveness (Phase 2)Active Not RecruitingNCT03245541
What this trial is testing

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04396821
What this trial is testing

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerGastric CancerGastroesophageal-junction Cancer+1 more
Transcenta Therapeutics (Hangzhou) Co., Ltd. 150
Not applicableStudy completedNCT05078775
What this trial is testing

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma
Faeth Therapeutics 39
Testing effectiveness (Phase 2)Study completedNCT02767557
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients

Who this might be right for
Unresectable Pancreatic Carcinoma
Herlev Hospital 147
Early research (Phase 1)Active Not RecruitingNCT05539430
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction CancerEsophageal Cancer+1 more
Legend Biotech USA Inc 56
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Study completedNCT03699319
What this trial is testing

CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
David Bajor, MD 49
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Early research (Phase 1)Not Yet RecruitingNCT06346808
What this trial is testing

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Who this might be right for
Pancreatic Cancer
Sichuan University 20
Testing effectiveness (Phase 2)UnknownNCT06475326
What this trial is testing

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fudan University 87
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07153289
What this trial is testing

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Who this might be right for
Carcinoma, Pancreatic DuctalPancreatic Neoplasms
University Hospital Tuebingen 38
Testing effectiveness (Phase 2)Looking for participantsNCT06789679
What this trial is testing

Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 128
Testing effectiveness (Phase 2)Ended earlyNCT03599362
What this trial is testing

Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 7
Next Page